Tango Therapeutics, Inc. · NASDAQ:TNGX
Woodline Partners LP reported a 7.50% stake in Tango Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Woodline Partners LP reported a 7.50% stake in Tango Therapeutics, Inc., 10,072,225 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 7.50%
- Shares
- 10,072,225
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Woodline Partners LP | 7.50% | 10,072,225 |
Source
Related
- Tango Therapeutics, Inc.
- Woodline Partners LP
- Tango Therapeutics, Inc. shareholders
- Schedule 13G/A · Woodline Partners LP · Aug 14, 2026
- Schedule 13G/A · Woodline Partners LP · May 15, 2026
- Schedule 13G · Woodline Partners LP · Aug 14, 2025
- Form 4 · Crystal Adam · Oct 5, 2026
- Form 4 · Newcomb Jessica · Sep 24, 2026
- Form 4 · Crystal Adam · Sep 3, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · Goldman Sachs Group Inc · Aug 14, 2026